ng-nitroarginine methyl ester has been researched along with Diabetic Glomerulosclerosis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Corremans, R; D'Haese, PC; Verhulst, A; Vervaet, BA | 1 |
| Aziz, NM; El-Tahawy, NF; Elbassuoni, EA | 1 |
| Gueler, F; Gutberlet, M; Hartung, D; Hueper, K; Husen, B; Reiche, D; Sann, H; Wacker, F | 1 |
| Edgley, AJ; Evans, RG; Parkington, HC; Skordilis, C; Tare, M | 1 |
| Bell, TD; Biemiller, R; Brands, MW; DiBona, GF | 1 |
| Anderson, S; Chapman, JG; Komers, R; Oyama, TT | 1 |
| Arellano-Mendoza, MG; Castorena-Torres, F; Coronel, I; del Valle-Mondragon, L; Escalante, B; Rios, A; Romo, E; Vargas-Robles, H | 1 |
| Iaina, A; Levin-Iaina, N; Raz, I | 1 |
| Erley, CM; Friedrich, B; Heyne, N; Osswald, H; Schmidt, T; Strobel, U; Wehrmann, M | 1 |
| Bellini, G; Bernobich, E; Bonavita, M; Cosenzi, A; Gris, F; Odoni, G | 1 |
| Craven, PA; DeRubertis, FR; Melhem, MF; Salah, EM | 1 |
| Li, F; Sima, AA; Stevens, MJ; Zhang, W | 1 |
| Higa, M; Inokuchi, T; Nagai, Y; Nakanishi, K; Onuma, S | 1 |
| Higuchi, M; Hora, K; Kamijo, H | 1 |
| Allen, TJ; Cooper, ME; Komers, R | 1 |
| Macdonald, GJ; Peake, P; Pussell, BA; Wessels, J | 1 |
| Hayashi, Y; Hiragushi, K; Kushiro, M; Makino, H; Matsuda, M; Shikata, K; Sugimoto, H; Wada, J | 1 |
| Choi, KC; Kang, YJ; Kim, NH; Kim, SW; Lee, JU; Lee, SC | 1 |
| Böhmer, KP; Haas, A; Hartner, A; Hilgers, KF; Sterzel, RB; Veelken, R | 1 |
| Allison, KM; Anderson, S; Komers, R; Lindsley, JN; Oyama, TT | 1 |
| De Vriese, AS; Devuyst, O; Elger, M; Kriz, W; Lameire, NH; Stoenoiu, MS; Vanholder, R | 1 |
21 other study(ies) available for ng-nitroarginine methyl ester and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Male; NAD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2021 |
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
Topics: Angiotensin II; Animals; Biomarkers; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Islets of Langerhans; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
Topics: Animals; Arteries; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Diet, High-Fat; Diffusion; Diffusion Tensor Imaging; Enzyme Inhibitors; Hemodynamics; Kidney; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 2013 |
In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes.
Topics: Acetylcholine; Anesthesia; Animals; Animals, Outbred Strains; Biological Factors; Blood Pressure; Bradykinin; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Inhibitors; Hyperemia; Indomethacin; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Wistar; Renal Circulation; Vasodilation; Vasodilator Agents | 2008 |
Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glomerular Filtration Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Artery; Renal Circulation | 2008 |
Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Orchiectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Testosterone | 2010 |
L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Enzyme Inhibitors; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vitamin E | 2010 |
The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hypertrophy; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Rats | 2011 |
Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
Topics: Animals; Arginine; Diabetic Nephropathies; Enzyme Inhibitors; Hemodynamics; Hypertension, Renal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2002 |
Role of nitric oxide in the early renal changes induced by high fructose diet in rats.
Topics: Animal Feed; Animals; Diabetic Nephropathies; Dietary Sucrose; Enzyme Inhibitors; Fructose; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred WKY | 2002 |
Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction.
Topics: Animals; Base Sequence; Cyclic GMP; Diabetic Nephropathies; DNA Primers; Humans; Immunohistochemistry; Inulin; Kidney; Kidney Glomerulus; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Reverse Transcriptase Polymerase Chain Reaction; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Transforming Growth Factor beta | 2004 |
C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
Topics: Animals; Body Weight; C-Peptide; Diabetic Nephropathies; Enzyme Inhibitors; Hindlimb; Hot Temperature; Hyperalgesia; Insulin; Lipid Peroxidation; Male; Motor Neurons; Nerve Tissue; Neural Conduction; Neurons, Afferent; NG-Nitroarginine Methyl Ester; Oxidative Stress; Oxidoreductases; Rats; Rats, Inbred BB; Rats, Zucker; Reaction Time; Regional Blood Flow | 2004 |
The intrarenal blood flow distribution and role of nitric oxide in diabetic rats.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Streptozocin | 2005 |
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Proteinuria; Rats; Rats, Inbred OLETF; Time Factors | 2006 |
Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Topics: Animals; Arginine; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Renal Circulation | 1994 |
Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR | 1997 |
Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Topics: Animals; Arterioles; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Inhibitors; Histocytochemistry; Insulin; Kidney; Kidney Glomerulus; Male; NADPH Dehydrogenase; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Rats; Rats, Sprague-Dawley | 1998 |
Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renal Circulation | 1999 |
Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Topics: Animals; Blood Pressure Determination; Blotting, Northern; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Isoenzymes; Kidney Function Tests; Kidney Glomerulus; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin | 2000 |
Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.
Topics: Animals; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Thiourea; Vascular Resistance | 2000 |
Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
Topics: Animals; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Inhibitors; Female; Hydronephrosis; Kidney; Microcirculation; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Rats; Rats, Wistar; Renal Circulation; Tissue Distribution; Vasodilation | 2001 |